Chart - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Export Countries
2018
2019
2020
2021
2022
Belgium
55.188.218
44.128.028
54.168.661
154.427.088
497.362.301
United States
302.049
662.786
460.797
115.231.633
184.684.034
France
23.873.443
30.029.184
50.448.567
40.183.790
53.542.932
Russia
22.329.303
28.245.634
26.229.091
20.335.050
Japan
6.906.318
14.281.775
22.585.842
4.641.839
5.039.863
South Korea
6.353.000
7.334.000
9.192.000
21.555.000
6.452.000
Netherlands
204.577
3.616.448
4.786
21.914.488
134.052
China
4.169.990
3.997.236
4.180.363
4.968.392
859.260
Germany
1.363.770
1.984.720
2.315.152
2.182.950
1.278.905
Brazil
941
6.000
1.330.706
5.756.779
Others
4.305.996
5.009.216
4.753.152
5.492.563
4.283.180
Total
124,996,663
139,289,968
174,344,410
392,263,499
759,393,307
Chart - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Nigeria - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Date
Export Countries
05 - 2023
06 - 2023
07 - 2023
08 - 2023
09 - 2023
10 - 2023
France
9.426.736
2.520.730
3.756
8.004.289
3.264.690
694.587
Netherlands
11.509
11.082.995
12.642.436
10.216
5.475
19.466
Belgium
4.505.493
6.314.839
1.861.649
6.693.149
3.925.513
75.674
Brazil
607
36.266
2.669.568
South Korea
668.000
48.000
487.000
8.000
72.000
Japan
522.621
461.897
Denmark
170.716
337.172
70.992
183.999
1.302
201.174
Italy
127.050
588.214
14.894
Israel
44.000
101.000
58.000
251.000
167.000
55.000
Germany
100.082
168.487
131.750
85.153
59.343
8.878
Others
175.678
316.570
167.811
443.253
319.121
112.241
Total
14,434,821
21,509,793
15,111,443
16,746,271
8,324,224
4,370,485
Chart - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Import Countries
2018
2019
2020
2021
2022
France
389.992
19
474
956
23
United States
39.050
16.116
Italy
22.665
Ireland
435
7.047
12.881
Germany
2.559
1.684
4.262
3.659
4.872
Sweden
09
1.864
1.978
10.525
Spain
4.034
995
754
1.312
4.428
United Kingdom
2.498
Netherlands
150
134
14
37
813
Canada
158
393
399
Others
410
802
91
181
178
Total
399,811
5,892
45,480
53,952
33,720
Chart - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Nigeria - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Date
Import Countries
05 - 2023
06 - 2023
07 - 2023
08 - 2023
09 - 2023
10 - 2023
Germany
483
272
197
49.915
242
194
United States
37.679
Belgium
883
365
637
280
580
1.036
Sweden
3.563
Ireland
472
408
402
642
717
193
Spain
515
407
149
207
213
634
France
800
653
South Korea
1.000
Portugal
55
244
Netherlands
01
80
82
Others
46
03
04
03
03
73
Total
2,399
1,512
2,388
51,128
40,476
6,428
Chart - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Chart - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Table - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD
Date
Export Countries
2018
2019
2020
2021
2022
Importaciones
Belgium
55.188.218
44.128.028
54.168.661
154.427.088
497.362.301
United States
302.049
662.786
460.797
115.231.633
184.684.034
France
23.873.443
30.029.184
50.448.567
40.183.790
53.542.932
Russia
22.329.303
28.245.634
26.229.091
20.335.050
Japan
6.906.318
14.281.775
22.585.842
4.641.839
5.039.863
South Korea
6.353.000
7.334.000
9.192.000
21.555.000
6.452.000
Netherlands
204.577
3.616.448
4.786
21.914.488
134.052
China
4.169.990
3.997.236
4.180.363
4.968.392
859.260
Germany
1.363.770
1.984.720
2.315.152
2.182.950
1.278.905
Brazil
941
6.000
1.330.706
5.756.779
Others
4.305.996
5.009.216
4.753.152
5.492.563
4.283.180
Total
124,996,663
139,289,968
174,344,410
392,263,499
759,393,307
Date
Import Countries
2018
2019
2020
2021
2022
Exportaciones
France
389.992
19
474
956
23
United States
39.050
16.116
Italy
22.665
Ireland
435
7.047
12.881
Germany
2.559
1.684
4.262
3.659
4.872
Sweden
09
1.864
1.978
10.525
Spain
4.034
995
754
1.312
4.428
United Kingdom
2.498
Netherlands
150
134
14
37
813
Canada
158
393
399
Others
410
802
91
181
178
Total
399,811
5,892
45,480
53,952
33,720
Chart - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Chart - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD
Table - Nigeria - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD